Searchable abstracts of presentations at key conferences in endocrinology

ea0070ep543 | Hot topics (including COVID-19) | ECE2020

Are women with osteoporosis treated with denosumab at risk of severe COVID-19?

Maria Formenti Anna , Pedone Erika , Di Filippo Luigi , Massimo Ulivieri Fabio , Giustina Andrea

Coronavirus disease 2019 (COVID-19), is a primarily respiratory infection which can lead to severe syndrome needing hospitalization and assisted ventilation with high lethality. In a recent meta-analysis of 33 RCTs increased risk of severe infections on treatment with Denosumab, widely used for treatment of osteoporosis, was found specifically for ear, nose, and throat. In fact, by inhibiting the receptor activator of nuclear factor κ-Β ligand, denosumab acts as an i...

ea0090p578 | Calcium and Bone | ECE2023

Assessment of dxa derived bone geometry parameters in early breast cancer patients: a cross-sectional study

Vena Walter , Pedersini Rebecca , Cosentini Deborah , Rinaudo Luca , Zamparini Manuel , Massimo Ulivieri Fabio , Mauro Pierluigi Di , Maffezzoni Filippo , Monteverdi Sara , Laini Lara , Amoroso Vito , Lucia Simoncini Edda , Farina Davide , Gerardo Lania Andre , Berruti Alfredo , Mazziotti Gherardo

Introduction: Bone mineral density (BMD) is considered a valid surrogate of bone strength in postmenopausal women, however it lacks sensitivity in individual fracture risk assessment in the setting of women with early breast cancer (EBC) patients treated with aromatase inhibitors (AIs). Indeed, mechanical resistance of bone only partially depends on bone quantity, and bone geometry and size play an important role in bone resistance to fractures. In this cross-sectional study, ...